On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...